O-09: DURABLE ENGRAFTMENT AFTER PHARMACOLOGICAL PRE-TRANSPLANT IMMUNOSUPPRESSION FOLLOWED BY REDUCED-TOXICITY MYELOABLATIVE HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN HIGHLY HLA-IMMUNIZED ADULTS WITH SICKLE CELL DISEASE

• FÜRST S.,
• BERNIT E.,
• GRANATA A.,
• LEGRAND F.,
• HARBI S.,
• DEVILLIER R.,
• MAISANO V.,
• BOUCHACOURT B.,
• PAGLIARDINI T.,
• MOKART D.,
• LEMARIÉ C.,
• CALMELS B.,
• PICARD C.,
• BASIRE A.,
• CHABANNON C.,
• ANDERSSON B.,
• BLAISE D.

Affiliations

FÜRST S.

1 Institut Paoli Calmettes, Marseille, FRANCE

BERNIT E.

3 Centre Hospitalier Universitaire, Pointe-à-Pitre, GUADELOUPE

GRANATA A.

1 Institut Paoli Calmettes, Marseille, FRANCE

LEGRAND F.

1 Institut Paoli Calmettes, Marseille, FRANCE

HARBI S.

1 Institut Paoli Calmettes, Marseille, FRANCE

DEVILLIER R.

1 Institut Paoli Calmettes, Marseille, FRANCE

MAISANO V.

1 Institut Paoli Calmettes, Marseille, FRANCE

BOUCHACOURT B.

1 Institut Paoli Calmettes, Marseille, FRANCE

PAGLIARDINI T.

1 Institut Paoli Calmettes, Marseille, FRANCE

MOKART D.

1 Institut Paoli Calmettes, Marseille, FRANCE

LEMARIÉ C.

1 Institut Paoli Calmettes, Marseille, FRANCE

CALMELS B.

1 Institut Paoli Calmettes, Marseille, FRANCE

PICARD C.

2 Etablissement Français du Sang, Marseille, FRANCE

BASIRE A.

2 Etablissement Français du Sang, Marseille, FRANCE

CHABANNON C.

1 Institut Paoli Calmettes, Marseille, FRANCE

ANDERSSON B.

4 University of Texas MD Anderson Cancer Center, Houston, UNITED STATES

BLAISE D.

1 Institut Paoli Calmettes, Marseille, FRANCE